A Study to Learn About Sickle Cell Disease In Adult Patients

CompletedOBSERVATIONAL
Enrollment

98

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

June 24, 2024

Study Completion Date

June 24, 2024

Conditions
Sickle Cell Disease
Interventions
OTHER

Electronic Diary

Participants will be asked to complete a daily electronic patient reported outcome diary entry to report on their experience in the past 24 hours.

Trial Locations (5)

11040

Cohen Children's Medical Center, New Hyde Park

20774

Mid-Atlantic Permanente Medical Group Largo Medical Center, Largo

Mid-Atlantic Permanente Medical Group Largo Medical Center, Upper Marlboro

33024

Foundation for Sickle Cell Disease Research, Hollywood

02451

Sanguine Biosciences, Inc., Waltham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05407805 - A Study to Learn About Sickle Cell Disease In Adult Patients | Biotech Hunter | Biotech Hunter